Ivan Kodvanj

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Coronavirus Disease

Cross Sectional

Top Venues

Molecular nutrition & food research

Clinical drug investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Vladimir Trkulja, Ivan Kodvanj
Outpatients prescribed with fluvoxamine around the time of COVID-19 diagnosis are not at a reduced risk of subsequent hospitalization and death compared to their non-prescribed peers: population-based matched cohort study. European journal of clinical pharmacology (2023)
Ivan Kodvanj, Jan Homolak, Davor Virag, Vladimir Trkulja
Publishing of COVID-19 preprints in peer-reviewed journals, preprinting trends, public discussion and quality issues. Scientometrics 127 (3) (2022)
Ivan Kodvanj, Jan Homolak, Vladimir Trkulja
People exposed to proton-pump inhibitors shortly preceding COVID-19 diagnosis are not at an increased risk of subsequent hospitalizations and mortality: A nationwide matched cohort study. British journal of clinical pharmacology (2022)
Jan Homolak, Ivan Kodvanj, Vladimir Trkulja
An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19. Clinical drug investigation 41 (3) (2021)
Vilim Molnar, Vid Matišić, Ivan Kodvanj, Roko Bjelica, Željko Jeleč, Damir Hudetz, Eduard Rod, Fabijan Čukelj, Trpimir Vrdoljak, Dinko Vidović, Mario Starešinić, Srećko Sabalić, Borut Dobričić, Tadija Petrović, Darko Antičević, Igor Borić, Rok Košir, Uršula Prosenc Zmrzljak, Dragan Primorac
Cytokines and Chemokines Involved in Osteoarthritis Pathogenesis. International journal of molecular sciences 22 (17) (2021)
Jan Homolak, Ana Babic Perhoc, Ana Knezovic, Ivan Kodvanj, Davor Virag, Jelena Osmanovic Barilar, Peter Riederer, Melita Salkovic-Petrisic
Is Galactose a Hormetic Sugar? An Exploratory Study of the Rat Hippocampal Redox Regulatory Network. Molecular nutrition & food research 65 (21) (2021)
Vladimir Trkulja, Ivan Kodvanj, Jan Homolak
Immunoglobulin G glycome and severity of COVID-19: more likely a quantification of bias than a true association. A comment on Petrović et al., "Composition of the immunoglobulin G glycome associates with the severity of COVID-19". Glycobiology 31 (7) (2021)